Marketing-authorisation holder · Canada
Servier Canada Inc
39 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Canada
39 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 39
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ASPARLAS3750 unit / 5 ml · Solution | Calaspargase pegol | Canada | Marketed | 2024 |
| COVERSYL8 mg · Tablet | Perindopril | Canada | Marketed | 2003 |
| COVERSYL4 mg · Tablet | Perindopril | Canada | Marketed | 1994 |
| COVERSYL2 mg · Tablet | Perindopril | Canada | Marketed | 1994 |
| COVERSYL PLUS1.25 mg + 4 mg · Tablet | Indapamide, Perindopril | Canada | Marketed | 2002 |
| COVERSYL PLUS HD2.5 mg + 8 mg · Tablet | Indapamide, Perindopril | Canada | Marketed | 2009 |
| COVERSYL PLUS LD0.625 mg + 2 mg · Tablet | Indapamide, Perindopril | Canada | Marketed | 2003 |
| DIAMICRON MR60 mg · Tablet (Extended-Release) | Gliclazide | Canada | Marketed | 2010 |
| DIAMICRON MR30 mg · Tablet (Extended-Release) | Gliclazide | Canada | Marketed | 2001 |
| FOLOTYN40 mg / 2 ml · Solution | Pralatrexate% | Canada | Authorised | |
| FOLOTYN20 mg / ml · Solution | Pralatrexate% | Canada | Marketed | 2019 |
| LANCORA5 mg · Tablet | Ivabradine | Canada | Marketed | 2017 |
| LANCORA7.5 mg · Tablet | Ivabradine | Canada | Marketed | 2017 |
| ONCASPAR750 unit / ml · Solution | Pegaspargase | Canada | Marketed | 2017 |
| TIBSOVO250 mg · Tablet (Immediate-Release) | Ivosidenib | Canada | Marketed | 2024 |
| VIACORAM5 mg + 7 mg · Tablet | Amlodipine, Perindopril | Canada | Marketed | 2016 |
| VIACORAM2.5 mg + 3.5 mg · Tablet | Amlodipine, Perindopril | Canada | Marketed | 2016 |
| VIACORAM10 mg + 14 mg · Tablet | Amlodipine, Perindopril | Canada | Marketed | 2016 |
| VORANIGO10 mg · Tablet | Vorasidenib | Canada | Marketed | 2024 |
| VORANIGO40 mg · Tablet | Vorasidenib | Canada | Marketed | 2024 |
| ARCOSYL2.5 mg · Tablet | Perindopril | Canada | Cancelled | |
| ARCOSYL5 mg · Tablet (Orally-Disintegrating) | Perindopril | Canada | Cancelled | |
| ARCOSYL2.5 mg · Tablet (Orally-Disintegrating) | Perindopril | Canada | Cancelled | |
| ARCOSYL10 mg · Tablet | Perindopril | Canada | Cancelled | |
| ARCOSYL5 mg · Tablet | Perindopril | Canada | Cancelled |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 39 | 20 | 19 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.